OPS

or

Free TMS or Spravato® consultations for patients with treatment-resistant depression

Spravato for Treatment Resistant Depression: What Patients in Central Ohio Should Know

Doctor supporting patient during Spravato treatment for treatment resistant depression

If you’ve tried multiple antidepressants and still don’t feel like yourself, it can be discouraging and exhausting. Treatment‑resistant depression (TRD) is more common than many people realize, and it does not mean you have run out of options or it is a sign that you are not trying hard enough. Advances in depression treatment, including Spravato (esketamine), are offering renewed hope to individuals who have struggled to find relief through traditional approaches.

Spravato (esketamine) nasal spray was developed specifically for adults in this situation. It is the only FDA‑approved nasal spray for treatment‑resistant depression and can be used on its own or alongside an oral antidepressant. For people seeking advanced depression treatment or alternatives to antidepressants in Columbus, Ohio area, understanding how Spravato works and what the research shows can make next steps feel clearer and more hopeful.

How Spravato Works in the Brain

Most antidepressants gradually change serotonin or norepinephrine levels and often take several weeks to work. Spravato targets a different system: the glutamate pathway.

Esketamine briefly blocks NMDA receptors, triggering a surge of glutamate and activating AMPA receptors. This increases a growth factor (BDNF) that supports neuroplasticity, the brain’s ability to form new, healthier connections. In depression, brain pathways can become rigid and locked into negative patterns. Spravato helps interrupt those patterns and gives your brain a chance to ‘reset’ and build new routes instead of staying stuck in the same loop.

Because it acts directly on these circuits, some patients notice a shift in symptoms within hours to days, rather than waiting weeks as with standard antidepressants alone.

How Quickly Spravato Starts to Work

A key difference between Spravato and many oral antidepressants is speed. While typical medications may take four to six weeks to show full effect, Spravato often acts sooner.

Many people experience a pattern like this:

  • Within 24 hours: Some patients report subtle improvements, such as feeling less overwhelmed or experiencing a much lower intensity of their symptoms or reduced suicidal thinking.
  • First 1–2 weeks: Improvements become more consistent as the brain responds to repeated doses.
  • By about 4 weeks: During the induction phase, many patients see more stable and significant relief.

Each person’s course is unique. How long you have been depressed, what you have already tried, other medical conditions, and whether you are also in therapy or TMS will all influence how quickly and how strongly you respond.

What the Evidence Shows

Clinical trials and real‑world data show that Spravato can bring meaningful relief to adults with treatment‑resistant depression who have not improved enough with at least two antidepressants. These results are especially important because they come from a group that is often hardest to treat.

Studies have found:

  • Rapid symptom reduction for many patients within the first month.
  • Some individuals notice benefit within 24 hours of the first dose.
  • Patients who continue Spravato as maintenance treatment are less likely to relapse than those who stop after an initial response.

People who respond often describe clearer thinking, better energy, renewed interest in activities, and a stronger ability to connect with others, not just a small lift in mood.

What Spravato Treatment Looks Like at OPS

Ohio Psychiatric Services provides Spravato treatment in Columbus and Lancaster, Ohio in a structured, supportive setting.

Step 1: Comprehensive evaluation

Your care starts with a psychiatric evaluation. A psychiatrist reviews your depression history, previous medications, current symptoms, and medical background to confirm whether Spravato is appropriate and safe. This visit is also a time to discuss your goals and concerns.

Step 2: Insurance review and approval

If Spravato appears to be a good fit, the OPS team helps with insurance verification and prior authorization. Many major insurance plans now provide coverage for Spravato for treatment‑resistant depression, when medical necessity criteria are met, although prior authorization is typically required. Trained staff will explain the expected costs and scheduling so you know what to expect.

Step 3: Induction phase (first month)

Once approved, you start the induction phase:

  • Treatments typically occur twice a week for four weeks.
  • You self‑administer the nasal spray in a private room under direct clinical supervision.
  • Doses are given in a sequence of sprays spaced a few minutes apart.
  • After dosing, you stay for at least two hours while staff monitor your blood pressure, level of alertness, and side effects.

Because Spravato can cause temporary sedation or dissociation, you will need a ride home and should not drive or operate machinery for the rest of the day. Spravato cannot be taken at home; all doses are given in a certified clinic under a REMS safety program.

Step 4: Maintenance phase

If you respond to Spravato, your psychiatrist will transition you to a maintenance schedule. Many people start with weekly sessions and then move to every one to two weeks as symptoms stabilize. The goal is to maintain progress with the lowest effective treatment frequency.

Spravato may be used on its own or combined with an oral antidepressant, allowing your provider to tailor your plan to your history, preferences, and side‑effect profile.

Side Effects and Safety

Most Spravato side effects are short‑lived and occur around the time of each treatment. Many people find side effects lessen as they continue treatment and become more familiar with the process. Common experiences include:

  • Feeling detached or floaty (dissociation)
  • Dizziness or unsteadiness
  • Nausea
  • Temporary rises in blood pressure
  • Sleepiness or fatigue

These are the main reasons treatment happens in a clinic with monitoring instead of at home. Some patients also describe the treatment experience as calming or reflective. Having a dedicated team present throughout the monitoring period often helps patients feel reassured and supported.

Spravato may not be right for everyone. Aneurysmal vascular disease, a history of brain hemorrhage (stroke), severe or uncontrolled hypertension or pregnancy may make other treatment options more suitable. Your OPS psychiatrist will review your medical history and current medications carefully before starting.

Why Consider Spravato at Ohio Psychiatric Services?

At OPS, Spravato is one part of a broader, personalized approach to depression care in Central Ohio. In addition to esketamine therapy, we also offer:

  • TMS therapy in Columbus and Hilliard, Ohio
  • Comprehensive medication management
  • Counseling and psychotherapy
  • Psychiatric evaluations
  • Genetic testing and other advanced options

This allows your treatment‑resistant depression plan in Columbus, Ohio to be built around you, not just a single medication or procedure. For some people, Spravato is the missing piece that finally moves the needle after years of trial and error. For others, it becomes a key part of a combined strategy that includes TMS, medication adjustments, and therapy.

If you have tried multiple medications and continue to struggle with depression, you do not have to navigate the next steps alone. The team at Ohio Psychiatric Services can help you determine whether Spravato, TMS, or another advanced treatment option may be right for you and create a personalized plan designed to help you regain hope and improve your quality of life.